Tong Fu1, Xenia Kobeleva2,3, Paul Bronzlik1, Patrick Nösel1, Mete Dadak1, Heinrich Lanfermann1, Susanne Petri2, Xiao-Qi Ding1. 1. Institute of Diagnostic and Interventional Neuroradiology, Hannover Medical School, 30625 Hannover, Germany. 2. Department of Neurology and Neurophysiology, Hannover Medical School, 30625 Hannover, Germany. 3. Department of Neurology, University of Bonn, 53127 Bonn, Germany.
Abstract
(1) Purpose: Quantitative magnetic resonance imaging (qMRI) measurements can be used to sensitively estimate brain morphological alterations and may support clinical diagnosis of neurodegenerative diseases (ND). We aimed to establish a normative reference database for a clinical applicable quantitative MR morphologic measurement on neurodegenerative changes in patients; (2) Methods: Healthy subjects (HCs, n = 120) with an evenly distribution between 21 to 70 years and amyotrophic lateral sclerosis (ALS) patients (n = 11, mean age = 52.45 ± 6.80 years), as an example of ND patients, underwent magnetic resonance imaging (MRI) examinations under routine diagnostic conditions. Regional cortical thickness (rCTh) in 68 regions of interest (ROIs) and subcortical grey matter volume (SGMV) in 14 ROIs were determined from all subjects by using Computational Anatomy Toolbox. Those derived from HCs were analyzed to determine age-related differences and subsequently used as reference to estimate ALS-related alterations; (3) Results: In HCs, the rCTh (in 49/68 regions) and the SGMV (in 9/14 regions) in elderly subjects were less than those in younger subjects and exhibited negative linear correlations to age (p < 0.0007 for rCTh and p < 0.004 for SGMV). In comparison to age- and sex-matched HCs, the ALS patients revealed significant decreases of rCTh in eight ROIs, majorly located in frontal and temporal lobes; (4) Conclusion: The present study proves an overall grey matter decline with normal ageing as reported previously. The provided reference may be used for detection of grey matter alterations in neurodegenerative diseases that are not apparent in standard MR scans, indicating the potential of using qMRI as an add-on diagnostic tool in a clinical setting.
(1) Purpose: Quantitative magnetic resonance imaging (qMRI) measurements can be used to sensitively estimate brain morphological alterations and may support clinical diagnosis of neurodegenerative diseases (ND). We aimed to establish a normative reference database for a clinical applicable quantitative MR morphologic measurement on neurodegenerative changes in patients; (2) Methods: Healthy subjects (HCs, n = 120) with an evenly distribution between 21 to 70 years and amyotrophic lateral sclerosis (ALS) patients (n = 11, mean age = 52.45 ± 6.80 years), as an example of NDpatients, underwent magnetic resonance imaging (MRI) examinations under routine diagnostic conditions. Regional cortical thickness (rCTh) in 68 regions of interest (ROIs) and subcortical grey matter volume (SGMV) in 14 ROIs were determined from all subjects by using Computational Anatomy Toolbox. Those derived from HCs were analyzed to determine age-related differences and subsequently used as reference to estimate ALS-related alterations; (3) Results: In HCs, the rCTh (in 49/68 regions) and the SGMV (in 9/14 regions) in elderly subjects were less than those in younger subjects and exhibited negative linear correlations to age (p < 0.0007 for rCTh and p < 0.004 for SGMV). In comparison to age- and sex-matched HCs, the ALSpatients revealed significant decreases of rCTh in eight ROIs, majorly located in frontal and temporal lobes; (4) Conclusion: The present study proves an overall grey matter decline with normal ageing as reported previously. The provided reference may be used for detection of grey matter alterations in neurodegenerative diseases that are not apparent in standard MR scans, indicating the potential of using qMRI as an add-on diagnostic tool in a clinical setting.
Authors: Christina Schuster; Elisabeth Kasper; Judith Machts; Daniel Bittner; Jörn Kaufmann; Reiner Benecke; Stefan Teipel; Stefan Vielhaber; Johannes Prudlo Journal: J Neurol Date: 2013-08-31 Impact factor: 4.849
Authors: Anders M Fjell; Lars T Westlye; Inge Amlien; Thomas Espeseth; Ivar Reinvang; Naftali Raz; Ingrid Agartz; David H Salat; Doug N Greve; Bruce Fischl; Anders M Dale; Kristine B Walhovd Journal: Cereb Cortex Date: 2009-01-15 Impact factor: 5.357
Authors: Ziad S Nasreddine; Natalie A Phillips; Valérie Bédirian; Simon Charbonneau; Victor Whitehead; Isabelle Collin; Jeffrey L Cummings; Howard Chertkow Journal: J Am Geriatr Soc Date: 2005-04 Impact factor: 5.562
Authors: Christina Schuster; Elisabeth Kasper; Judith Machts; Daniel Bittner; Jörn Kaufmann; Reiner Benecke; Stefan Teipel; Stefan Vielhaber; Johannes Prudlo Journal: J Neurol Date: 2014-07-15 Impact factor: 4.849
Authors: Peter Bede; Taha Omer; Eoin Finegan; Rangariroyashe H Chipika; Parameswaran M Iyer; Mark A Doherty; Alice Vajda; Niall Pender; Russell L McLaughlin; Siobhan Hutchinson; Orla Hardiman Journal: Brain Imaging Behav Date: 2018-12 Impact factor: 3.978
Authors: Esther Verstraete; Jan H Veldink; Jeroen Hendrikse; H Jurgen Schelhaas; Martijn P van den Heuvel; Leonard H van den Berg Journal: J Neurol Neurosurg Psychiatry Date: 2011-09-29 Impact factor: 10.154
Authors: D M Mezzapesa; A Ceccarelli; F Dicuonzo; A Carella; M F De Caro; M Lopez; V Samarelli; P Livrea; I L Simone Journal: AJNR Am J Neuroradiol Date: 2007-02 Impact factor: 3.825
Authors: Elijah Mak; Li Su; Guy B Williams; Michael J Firbank; Rachael A Lawson; Alison J Yarnall; Gordon W Duncan; Adrian M Owen; Tien K Khoo; David J Brooks; James B Rowe; Roger A Barker; David J Burn; John T O'Brien Journal: Brain Date: 2015-07-14 Impact factor: 13.501